Paula Kauppi
Overview
Explore the profile of Paula Kauppi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
689
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
von Bulow A, Hansen S, Sandin P, Cooper A, Ernstsson O, Geale K, et al.
J Allergy Clin Immunol Pract
. 2025 Feb;
PMID: 39900241
Background: The link between the use of oral corticosteroids (OCS) and adverse events (AEs) in asthma is well described. In contrast, whether the use of high-dose inhaled corticosteroids (ICS) poses...
2.
Pollock J, Pollock J, Goeminne P, Goeminne P, Aliberti S, Aliberti S, et al.
Chest
. 2024 Oct;
PMID: 39461553
Background: Aspergillus species cause diverse clinical manifestations in bronchiectasis including allergic bronchopulmonary aspergillosis (ABPA), Aspergillus sensitization (AS), and raised IgG indicating exposure to, or infection with, Aspergillus. Research Question: What...
3.
Genberg E, Kauppi P, Sahlman J, Laulajainen-Hongisto A, Lilja M, Hammaren-Malmi S, et al.
Clin Exp Allergy
. 2024 Jul;
54(12):999-1002.
PMID: 39054578
No abstract available.
4.
Spinou A, Hererro-Cortina B, Aliberti S, Goeminne P, Polverino E, Dimakou K, et al.
Eur Respir J
. 2024 Apr;
63(6).
PMID: 38609097
Background: International guidelines recommend airway clearance management as one of the important pillars of bronchiectasis treatment. However, the extent to which airway clearance is used for people with bronchiectasis in...
5.
Aliberti S, Ringshausen F, Dhar R, Haworth C, Loebinger M, Dimakou K, et al.
Eur Respir J
. 2024 Apr;
63(4).
PMID: 38609095
Background: A validated 4-point sputum colour chart can be used to objectively evaluate the levels of airway inflammation in bronchiectasis patients. In the European Bronchiectasis Registry (EMBARC), we tested whether...
6.
Polverino E, Dimakou K, Traversi L, Bossios A, Haworth C, Loebinger M, et al.
J Allergy Clin Immunol
. 2024 Feb;
153(6):1553-1562.
PMID: 38401857
Background: Asthma is commonly reported in patients with a diagnosis of bronchiectasis. Objective: The aim of this study was to evaluate whether patients with bronchiectasis and asthma (BE+A) had a...
7.
Polverino E, Soyza A, Dimakou K, Traversi L, Bossios A, Crichton M, et al.
Am J Respir Crit Care Med
. 2024 Jan;
210(1):119-127.
PMID: 38271696
COPD and bronchiectasis are commonly reported together. Studies report varying impacts of co-diagnosis on outcomes, which may be related to different definitions of disease used across studies. To investigate the...
8.
Jalasto J, Luukkonen R, Lindqvist A, Langhammer A, Kankaanranta H, Backman H, et al.
Int Arch Occup Environ Health
. 2023 Dec;
97(2):145-154.
PMID: 38112780
Purpose: Environmental particulate matter (PM) exposure has been shown to cause excess all-cause and disease-specific mortality. Our aim was to compare disease-specific mortality by estimated occupational exposure to vapors, gasses,...
9.
Thomander T, Toppila-Salmi S, Palosuo K, Voutilainen H, Kukkonen K, Pallasaho P, et al.
J Allergy Clin Immunol Pract
. 2023 Nov;
12(3):776-778.e2.
PMID: 37918650
No abstract available.
10.
von Bulow A, Hansen S, Sandin P, Ernstsson O, Janson C, Lehtimaki L, et al.
Eur Respir J
. 2023 Aug;
62(3).
PMID: 37620041
Background: There is limited evidence on the pathways leading to severe asthma and we are presently unable to effectively predict the progression of the disease. We aimed to describe the...